Genetic progression and the waiting time to cancer
- PMID: 17997597
- PMCID: PMC2065895
- DOI: 10.1371/journal.pcbi.0030225
Genetic progression and the waiting time to cancer
Abstract
Cancer results from genetic alterations that disturb the normal cooperative behavior of cells. Recent high-throughput genomic studies of cancer cells have shown that the mutational landscape of cancer is complex and that individual cancers may evolve through mutations in as many as 20 different cancer-associated genes. We use data published by Sjöblom et al. (2006) to develop a new mathematical model for the somatic evolution of colorectal cancers. We employ the Wright-Fisher process for exploring the basic parameters of this evolutionary process and derive an analytical approximation for the expected waiting time to the cancer phenotype. Our results highlight the relative importance of selection over both the size of the cell population at risk and the mutation rate. The model predicts that the observed genetic diversity of cancer genomes can arise under a normal mutation rate if the average selective advantage per mutation is on the order of 1%. Increased mutation rates due to genetic instability would allow even smaller selective advantages during tumorigenesis. The complexity of cancer progression can be understood as the result of multiple sequential mutations, each of which has a relatively small but positive effect on net cell growth.
Conflict of interest statement
Figures





Similar articles
-
Mutation, cell kinetics, and subpopulations at risk for colon cancer in the United States.Mutat Res. 1998 May 25;400(1-2):553-78. doi: 10.1016/s0027-5107(98)00067-0. Mutat Res. 1998. PMID: 9685710
-
Somatic evolution of cancer cells.Semin Cancer Biol. 2005 Dec;15(6):436-50. doi: 10.1016/j.semcancer.2005.06.001. Semin Cancer Biol. 2005. PMID: 16055343 Review.
-
Cytogenetic aberrations and heterogeneity of mutations in repeat-containing genes in a colon carcinoma from a patient with hereditary nonpolyposis colorectal cancer.Cancer Genet Cytogenet. 2002 Apr 1;134(1):46-54. doi: 10.1016/s0165-4608(01)00587-8. Cancer Genet Cytogenet. 2002. PMID: 11996796
-
Microsatellite instability of selective target genes in HNPCC-associated colon adenomas.Oncogene. 2005 Apr 7;24(15):2525-35. doi: 10.1038/sj.onc.1208456. Oncogene. 2005. PMID: 15735733
-
Molecular biology of colorectal cancer.Curr Probl Cancer. 1997 Sep-Oct;21(5):233-300. doi: 10.1016/s0147-0272(97)80003-7. Curr Probl Cancer. 1997. PMID: 9438104 Review.
Cited by
-
Cis-regulatory mutations with driver hallmarks in major cancers.iScience. 2021 Feb 4;24(3):102144. doi: 10.1016/j.isci.2021.102144. eCollection 2021 Mar 19. iScience. 2021. PMID: 33665563 Free PMC article.
-
Cancer's second genome: Microbial cancer diagnostics and redefining clonal evolution as a multispecies process: Humans and their tumors are not aseptic, and the multispecies nature of cancer modulates clinical care and clonal evolution: Humans and their tumors are not aseptic, and the multispecies nature of cancer modulates clinical care and clonal evolution.Bioessays. 2022 May;44(5):e2100252. doi: 10.1002/bies.202100252. Epub 2022 Mar 6. Bioessays. 2022. PMID: 35253252 Free PMC article. Review.
-
Elucidating the correlations between cancer initiation times and lifetime cancer risks.Sci Rep. 2019 Dec 12;9(1):18940. doi: 10.1038/s41598-019-55300-w. Sci Rep. 2019. PMID: 31831779 Free PMC article.
-
Competing evolutionary paths in growing populations with applications to multidrug resistance.PLoS Comput Biol. 2019 Apr 15;15(4):e1006866. doi: 10.1371/journal.pcbi.1006866. eCollection 2019 Apr. PLoS Comput Biol. 2019. PMID: 30986219 Free PMC article.
-
Oncodomains: A protein domain-centric framework for analyzing rare variants in tumor samples.PLoS Comput Biol. 2017 Apr 20;13(4):e1005428. doi: 10.1371/journal.pcbi.1005428. eCollection 2017 Apr. PLoS Comput Biol. 2017. PMID: 28426665 Free PMC article.
References
-
- Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nat Med. 2004;10:789–799. - PubMed
-
- Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57–70. - PubMed
-
- Knudson AG. Cancer genetics. Am J Med Genet. 2002;111:96–102. - PubMed
-
- Rajagopalan H, Nowak MA, Vogelstein B, Lengauer C. The significance of unstable chromosomes in colorectal cancer. Nat Rev Cancer. 2003;3:695–701. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources